Literature DB >> 15136079

Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.

.   

Abstract

OBJECTIVE: To summarize the procedures and outcomes of ART initiated in the United States in 2000.
DESIGN: Data were collected electronically using the SART Clinical Outcome Reporting System software and submitted to the American Society for Reproductive Medicine/ Society for Assisted Reproductive Technology Registry. PARTICIPANT(S): Three hundred eighty-three programs submitted data on procedures performed in 2000. Data were collated after November 2000 so that the outcome of all pregnancies established would be known. MAIN OUTCOME MEASURE(S): Incidence of clinical pregnancy, ectopic pregnancy, abortion, stillbirth, and delivery. RESULT(S): Programs reported initiating 99,989 cycles of ART treatment. Of these, 73,406 cycles involved fresh nondonor IVF (46.6% with intracytoplasmic sperm injection [ICSI]), with a delivery rate per retrieval of 29.9%; 549 were cycles of gamete intrafallopian transfer, with a delivery rate per retrieval of 24.7%; 763 were cycles of zygote intrafallopian transfer, with a delivery rate per retrieval of 29.9%. The following additional ART procedures were also initiated: 7,581 fresh donor oocyte cycles, with a delivery rate per transfer of 43.7%; 13,083 frozen embryo transfer procedures, with a delivery rate per transfer of 20.4%; 2,721 frozen embryo transfers using donated oocytes or embryos, with a delivery rate per transfer of 23.5%, and 1,200 cycles using a host uterus, with a delivery rate per transfer of 35.8%. In addition, 326 cycles were reported as combinations of more than one treatment type, 41 cycles as research, and 319 as embryo banking. As a result of all procedures, 25,394 deliveries were reported, resulting in 35,345 neonates, of which 35,031 were live born and 314 stillborn. CONCLUSION(S): In 2000, there were more programs reporting ART treatment and a significant (13.5%) increase in reported cycles compared to 1999. In comparable cycle types, overall success rate (deliveries per retrieval) exhibited an actual increase of 0.6%, which represents an increase of 2.2% when compared to the success rate for 1999.

Entities:  

Mesh:

Year:  2004        PMID: 15136079     DOI: 10.1016/j.fertnstert.2004.01.017

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Can the peak E2/follicle ratio be a quantitative indicator of pregnancy outcomes following assisted reproductive cycles? A retrospective study.

Authors:  Dan Hu; Xiyuan Dong; Min Xiong; Ting Xiong; Bo Huang; Dan Zeng; Jihui Ai; Hanwang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Low endometrial volume may predict early pregnancy loss in women undergoing in vitro fertilization.

Authors:  Efraim Zohav; Raoul Orvieto; Eyal Y Anteby; Octav Segal; Simion Meltcer; Ilan Tur-Kaspa
Journal:  J Assist Reprod Genet       Date:  2007-03-14       Impact factor: 3.412

Review 3.  The Oncofertility Consortium--addressing fertility in young people with cancer.

Authors:  Teresa K Woodruff
Journal:  Nat Rev Clin Oncol       Date:  2010-05-25       Impact factor: 66.675

4.  Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants.

Authors:  Daniel Paull; Valentina Emmanuele; Keren A Weiss; Nathan Treff; Latoya Stewart; Haiqing Hua; Matthew Zimmer; David J Kahler; Robin S Goland; Scott A Noggle; Robert Prosser; Michio Hirano; Mark V Sauer; Dieter Egli
Journal:  Nature       Date:  2012-12-19       Impact factor: 49.962

Review 5.  Utility of magnetic cell separation as a molecular sperm preparation technique.

Authors:  Tamer M Said; Ashok Agarwal; Maciej Zborowski; Sonja Grunewald; Hans-Juergen Glander; Uwe Paasch
Journal:  J Androl       Date:  2007-12-12

6.  Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.

Authors:  David Barad; Hyama Brill; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2007-12-11       Impact factor: 3.412

7.  Toxic trace metals and human oocytes during in vitro fertilization (IVF).

Authors:  Michael S Bloom; Patrick J Parsons; Amy J Steuerwald; Enrique F Schisterman; Richard W Browne; Keewan Kim; Gregory A Coccaro; Giulia C Conti; Natasha Narayan; Victor Y Fujimoto
Journal:  Reprod Toxicol       Date:  2010-01-22       Impact factor: 3.143

8.  Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.

Authors:  Christina E Boots; Micah J Hill; Eve C Feinberg; Ruth B Lathi; Susan A Fowler; Emily S Jungheim
Journal:  J Assist Reprod Genet       Date:  2016-03-04       Impact factor: 3.412

9.  Long-term outcomes in cancer patients who did or did not pursue fertility preservation.

Authors:  Molly B Moravek; Rafael Confino; Kristin N Smith; Ralph R Kazer; Susan C Klock; Angela K Lawson; William J Gradishar; Mary Ellen Pavone
Journal:  Fertil Steril       Date:  2018-01-17       Impact factor: 7.329

10.  Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol.

Authors:  D S Johnson; G Gemelos; J Baner; A Ryan; C Cinnioglu; M Banjevic; R Ross; M Alper; B Barrett; J Frederick; D Potter; B Behr; M Rabinowitz
Journal:  Hum Reprod       Date:  2010-01-24       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.